NEWS
Australia's Garvan Institute identifies four subtypes of pancreatic cancer genomes
FiercePharma
2015/03/02**SINGAPORE--**Researchers at Australia's Garvan Institute report in Nature they have been able to identify four subtypes of the 100 pancreatic cancer genomes, enhancing the possibility of finding the proper treatment. Joint work carried out UK researchers was able to detect structural variations that previously had been invisible. The finding means researchers now have the ability to zoom in and get more detail. Report | Garvan Institute release
Summary
Researchers at Australia's Garvan Institute report in the journal Nature they have been able to identify four subtypes of the 100 pancreatic cancer genomes, enhancing the possibility of finding the proper treatment.